These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12614344)

  • 41. Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.
    Kanekiyo T; Bu G
    J Biol Chem; 2009 Nov; 284(48):33352-9. PubMed ID: 19826010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of LRP-1 and apolipoprotein E on amyloid-β uptake and toxicity to cerebrovascular smooth muscle cells.
    Ruzali WA; Kehoe PG; Love S
    J Alzheimers Dis; 2013; 33(1):95-110. PubMed ID: 22914594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
    Guo L; LaDu MJ; Van Eldik LJ
    J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
    Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice.
    Keller JN; Lauderback CM; Butterfield DA; Kindy MS; Yu J; Markesbery WR
    J Neurochem; 2000 Apr; 74(4):1579-86. PubMed ID: 10737615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.
    Kang DE; Pietrzik CU; Baum L; Chevallier N; Merriam DE; Kounnas MZ; Wagner SL; Troncoso JC; Kawas CH; Katzman R; Koo EH
    J Clin Invest; 2000 Nov; 106(9):1159-66. PubMed ID: 11067868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration.
    Kuszczyk MA; Sanchez S; Pankiewicz J; Kim J; Duszczyk M; Guridi M; Asuni AA; Sullivan PM; Holtzman DM; Sadowski MJ
    Am J Pathol; 2013 May; 182(5):1750-68. PubMed ID: 23499462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein E influences amyloid-beta clearance from the murine periphery.
    Hone E; Martins IJ; Fonte J; Martins RN
    J Alzheimers Dis; 2003 Feb; 5(1):1-8. PubMed ID: 12590160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity.
    Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A
    Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver.
    Tamaki C; Ohtsuki S; Iwatsubo T; Hashimoto T; Yamada K; Yabuki C; Terasaki T
    Pharm Res; 2006 Jul; 23(7):1407-16. PubMed ID: 16779710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.